The integration of AI agents into the workplace introduces profound changes to biopharma companies’ operating models, challenging traditional notions of work distribution, team composition, and managerial oversight. Tasks that today are merely GenAI-enabled could soon be taken care of by an AI agent. Which archetype would you choose?